Biomarker ID | 1029 |
PMID | 23231923 |
Year | 2012 |
Biomarker | miR-30d |
Biomarker Basis | Expression Based |
Biomolecule | miRNA |
Source | Cell Lines |
Subjects | Humans |
Regulation | Upregulated in PCa Cell Lines (> 2 fold) |
Odds Ratio/Hazard Ratio/Relative Risk | NA |
Effect on Pathways | Pathways Include:- transcription by RNA polymerase II; regulation of transcription by RNA polymerase II; Gene expression (Transcription); cellular protein modification process; protein modification process |
Experiment | Normal Vs Cancerous Prostate Cell Lines |
Type of Biomarker | Diagnostic |
Cohort | Normal human prostate cell lines (epithelial cells, RWPE-1; stromal cells, PrSc), cancer cell lines (LNCaP, PC-3, and DU145) were used |
Senstivity | NA |
Specificity | NA |
AUC | NA |
Accuracy | NA |
Level Of Significance | p<0.05 |
Method Used | qRT-PCR |
Clinical | No |
Remarks | NA |
Clinical Trial Number | NA |
Degree Of Validity | Validated on independent patient dataset |
Technical Name | miR-30d |